hVIVO plc (LON:HVO – Get Free Report)’s share price was up 10% during mid-day trading on Monday . The stock traded as high as GBX 22 ($0.27) and last traded at GBX 21.25 ($0.26). Approximately 7,804,669 shares traded hands during mid-day trading, an increase of 164% from the average daily volume of 2,961,263 shares. The stock had previously closed at GBX 19.33 ($0.24).
hVIVO Trading Down 6.9 %
The company has a debt-to-equity ratio of 33.86, a quick ratio of 1.16 and a current ratio of 1.61. The business’s 50 day moving average price is GBX 20.01 and its 200-day moving average price is GBX 25.58. The company has a market cap of £129.27 million, a price-to-earnings ratio of 633.33 and a beta of 0.97.
hVIVO Company Profile
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Further Reading
- Five stocks we like better than hVIVO
- What Are Dividend Contenders? Investing in Dividend Contenders
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Steel Stocks Soaring After Tariff Announcements
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
